Committees
- Evidence-Based Recommendations Task Force (RTF)
- Central Review Committee (CRC)
- Implementtion Task force (ITF)
- Outcomes Research Task Force (ORTF)
STEERING COMMITTEE
A steering committee comprised of the Canadian Hypertension Society (CHS), Blood Pressure Canada (BP Canada), the Public Health Agency of Canada, the Heart and Stroke Foundation of Canada, the College of Family Physicians of Canada, the Canadian Council of Cardiovascular Nurses, the Canadian Pharmacists Association and the CHEP executive oversee CHEP.
Chair
Dr. Norman Campbell – CHEP Executive & Blood Pressure Canada
Members
Dr. Sheldon Tobe – CHEP Executive
Dr. Richard Lewanczuk – CHEP Executive
Dr. Finlay McAlister – CHEP Executive
Dr. Marshall Godwin – College of Family Physicians of Canada
Dr. Marcel Lebel – CHEP Executive
Ms. Margaret Moy Lum-Kwong – Heart and Stroke Foundation of Canada
Ms. Lianne Vardy – Public Health Agency of Canada
Dr. Janusz Kaczorowski – CHEP Executive
Ms. Sandra Matheson – Canadian Council of Cardiovascular Nurses
Mr. Luc Poirier – Canadian Pharmacists’ Association
Dr. Oliver Baclic – CHEP Executive
Dr. Rhian Touyz – Canadian Hypertension Society
EXECUTIVE COMMITTEE
The Chair and Vice-Chair of the Task Forces oversee CHEP strategic planning and the daily activities.
Dr. Norman Campbell – Chair, Outcomes RTF
Dr. Finlay McAlister
Dr. Oliver Baclic
Dr. Janusz Kaczorowski – Vice-Chair, ITF
Dr. Sheldon Tobe – Chair, Evidence-Based Recommendations Task Force (RTF)
Dr. Richard Lewanczuk – Vice-Chair, ITF
Dr. Marcel Lebel – Vice-Chair, RTF
TASK FORCES
Evidence-Based Recommendations Task Force (RTF)
The RTF has a unique process that is highly structured and systematic to reduce bias and that critically reviews evidence and updates clinical practice recommendations annually. Fifteen subgroups have been assigned topics important to the detection, treatment and control of hypertension. Systematic literature searches are performed by a librarian and each subgroup develops draft recommendations using an evidence-based grading scheme.
Chair
Dr. Sheldon Tobe
Vice-Chair
Dr. Marcel Lebel
Sub-Groups
Ambulatory Blood Pressure Monitoring
Dr. Martin Myers
Dr. Martin Dawes
Lifestyle Modification in Hypertension
Dr. Rhian Touyz
Dr. Rob Petrella
Dr. Norm Campbell
Dr. Luc Trudeau
Dr. Peter Katzmarzyk
Adherence Strategies for Patients
Dr. Tavis Campbell
Dr. Alain Milot
Dr. James Stone
Dr. Ross Feldman
Accurate Measurement of Blood Pressure
Dr. Carl Abbott
Dr. Karen Mann
Ms. Lyne Cloutier
Cardiovascular Risk Assessment
Dr. Steven Grover
Dr. Guy Tremblay
Dr. Alain Milot
Pharmacotherapy for Hypertensive Patients with Cardiovascular Disease
Dr. Simon Rabkin
Dr. Malcolm Arnold
Dr. Gordon Moe
Dr. Jean-Martin Boulanger
Echocardiography
Dr. George Honos
Pharmacotherapy for Hypertensive Patients Without Compelling Indications
Dr. Robert Herman
Dr. Pavel Hamet
Dr. George Fodor
Dr. George Carruthers
Dr. Bruce Culleton
Dr. Jacques de Champlain
Dr. George Pylypchuk
Endocrinological Forms of Hypertension
Dr. Ernesto Schiffrin
Renal & Renovascular Hypertension
Dr. Sheldon Tobe
Dr. Kevin Burns
Dr. Marcel Ruzicka
Dr. Marcel Lebel
Dr. Michel Vallee
Follow-Up on Patients with Hypertension
Dr. Peter Bolli
Dr. Guy Tremblay
Routine Laboratory Tests
Dr. Thomas Wilson
Dr. Brian Penner
Dr. Ellen Burgess
Hypertension & Diabetes
Dr. Pierre Larochelle
Dr. Lawrence Leiter
Dr. Charlotte Jones
Dr. Richard Ogilvie
Dr. Sheldon Tobe
Dr. Vincent Woo
Self-Measurement of Blood Pressure
Dr. Don McKay
Dr. Arun Chockalingam
Vascular Protection
Dr. Ernesto Schiffrin
Dr. Rob Hegele
Dr. Phil McFarlane
Dr. Ross Feldman
Central Review Committee (CRC)
This committee consists of 4-6 experts in evidence-based medicine and clinical epidemiology who do not have conflicts of interest. The CRC reviews the recommendations and evidence to ensure a consistent approach to the recommendations development and suggests revisions to the sub-groups. The evidence and draft recommendations are presented by the CRC and further revised at an annual meeting of the Recommendations Task Force.
Dr. Brenda Hemmelgarn
Dr. Finlay McAlister
Dr. Nadia Khan
Dr. Raj Padwal
Dr. Michael Hill
Dr. Jeff Mahon
Dr. Chaim Bell
Implementation Task Force (ITF)
The ITF develops key implementation messages, identifies important recommendations that must be emphasized, and develops an annual theme each year. The ITF is responsible for production of educational materials and the creation of a dissemination strategy. The ITF has a multidisciplinary membership including pharmacists, family doctors, nurses, medical specialists, a sociologist and an exercise physiologist. Membership is purposefully selected to include key regional and national opinion leaders. This Task Force tailors recommendations messaging for specific health care disciplines.
Chair
Dr. Denis Drouin
Vice-Chairs
Dr. Janusz Kaczorowksi & Dr. Richard Lewanczuk
Nurses
Ms. Jo-Anne Costello
Ms. Lyne Cloutier
Ms. Donna McLean
Ms. Sandra Matheson
Ms. Cindy Bolton
Ms. Teri Green
Family Physicians
Dr. Martin Dawes
Dr. John Hickey
Dr. Mark Gelfer
Pharmacists
Mr. Luc Poirier
Dr. William Semchuk
Dr. Ross Tsuyuki
Ms. Ann Thompson
Members at Large
Dr. Jean Martin Boulanger
Dr. Ross Feldman
Dr. Norm Campbell
Dr. Sheldon Tobe
Dr. Alain Milot
Dr. Guy Tremblay
Dr. Rhian Touyz
Mr. Jay Onysko
Dr. Faisal Jhandir
Dr. Anil Gupta
Dr. Richard Ward
Dr. Robert Petrella
Outcomes Research Task Force (ORTF)
The ORTF was developed to assess the treatment and control of hypertension in Canada to evaluate the effectiveness of CHEP. Five sub-groups examine:
- Hypertension Outcome and Surveillance Team (HOST) – administrative databases to track hypertension diagnosis, hypertension treatment, and complications of hypertension
- The hospitalization and mortality for acute stroke, acute myocardial infarction, and heart failure
- National health surveys to determine awareness of hypertension and treatment of hypertension
- National prescriptions of antihypertensive drugs
- Economics of hypertension
Chair
Dr. Finlay McAlister
Vice-Chair
Dr. Oliver Baclic
HOST
Members
Dr. Hude Quan (Principal Investigator)
Dr. Brenda Hemmelgarn (Co-Principal Investigator)
Dr. Karen Tu (Co-Principal Investigator)
Dr. Gillian Bartlett
Dr. Norm Campbell
Dr. Guanmin Chen
Dr. Michael Hill
Dr. Nadia Khan
Dr. Lisa Lix
Dr. Finelay McAlister
Dr. Mark Smith
Dr. Larry Svenson
Dr. Gary Teare
Ms. Robin Walker
Dr. Andrew Wielgosz
COLLABORATORS
Dr. Oliver Baclic
Ms. Patty Beck
Ms. Asako Bienek
Ms. Jill Casey
Ms. Winanne Downey
Mr. Kim Reimer
Hospitalization & Mortality
Members
Dr. Norm Campbell (Chair)
Ms. Asako Bienek
Dr. Rollin Brant
Dr. Guanmin Chen
Dr. Brenda Hemmelgarn
Dr. Helen Johansen
Dr. Stephen Phillips
Ms. Robin Walker
Dr. Andrew Wielgosz
National Health Surveys
Members
Dr. Femida Gwadry-Sridhar (Chair)
Ms. Asako Bienek
Dr. Norm Campbell
Dr. Ross Feldman
Dr. Michel Joffres
Dr. Janusz Kaczorowksi
Dr. Patty Lindsay
Dr. Colleen Maxwell
Ms. Marianne Nichol
Dr. Robert Nolan
Ms. Robin Walker
IMS Data Analysis (Prescriptions)
Members
Dr. Brenda Hemmelgarn (Chair)
Dr. Rollin Brant
Dr. Norm Campbell
Dr. Guanmin Chen
Dr. Nadia Khan
Dr. Hude Quan
Dr. Karen Tu
Ms. Robin Walker
Economic Analysis
Members
Dr. Scott Klarenbach (Chair)
Dr. Norm Campbell
Dr. Denis Drouin
Dr. Steven Grover
Dr. Helen Johansen
Mr. Chris Robinson
Dr. Karen Tu
Ms. Robin Walker
Dr. Kelly Zarnke
Several publications have been published on the changes in hypertension management & outcomes associated with the start of the CHEP.